Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Payne

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical and Experimental Immunology|June 1, 1986
Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosyS J Brett, S N Payne, J Gigg, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1985
Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patientsA Andreoli, S J Brett, P Draper, et al.
The British Journal of Dermatology|November 1, 1990
Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activityJ I Duncan, S N Payne, A J Winfield, et al.
Nature|October 29, 1971
Lesions due to complement in lipid membranesT R Hesketh, R R Dourmashkin, S N Payne, et al.
Oncogenesis|October 6, 2015
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitorsS N Payne, M E Maher, N H Tran, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical and Experimental Immunology|June 1, 1986
Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosyS J Brett, S N Payne, J Gigg, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1985
Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patientsA Andreoli, S J Brett, P Draper, et al.
The British Journal of Dermatology|November 1, 1990
Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activityJ I Duncan, S N Payne, A J Winfield, et al.
Nature|October 29, 1971
Lesions due to complement in lipid membranesT R Hesketh, R R Dourmashkin, S N Payne, et al.
Oncogenesis|October 6, 2015
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitorsS N Payne, M E Maher, N H Tran, et al.
Pageof 2